S 3537
Protecting Our Pharmaceutical Supply Chain from China Act of 2020
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Bill overview
The Protecting Our Pharmaceutical Supply Chain from China Act of 2020 aims to enhance the security and transparency of the U.S. drug supply. It requires the Health and Human Services Secretary to maintain a registry of drugs manufactured outside the United States, specifically tracking their supply chains and identifying those sourced exclusively from China. The bill also prohibits federal health programs from purchasing drugs containing Chinese-made ingredients, gradually increasing the required percentage of domestically manufactured active pharmaceutical ingredients. Finally, it offers tax incentives for companies building or expanding pharmaceutical and medical device manufacturing facilities in the U.S.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.